ProQR Therapeutics NV (PRQR)
2.01
+0.02
(+1.00%)
USD |
NASDAQ |
May 03, 16:00
2.02
+0.01
(+0.50%)
After-Hours: 20:00
ProQR Therapeutics Price to Book Value: 3.574 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.574 |
| May 02, 2024 | 3.538 |
| May 01, 2024 | 3.556 |
| April 30, 2024 | 3.450 |
| April 29, 2024 | 3.503 |
| April 26, 2024 | 3.450 |
| April 25, 2024 | 3.485 |
| April 24, 2024 | 3.574 |
| April 23, 2024 | 3.592 |
| April 22, 2024 | 3.556 |
| April 19, 2024 | 3.538 |
| April 18, 2024 | 3.307 |
| April 17, 2024 | 3.378 |
| April 16, 2024 | 3.556 |
| April 15, 2024 | 3.636 |
| April 12, 2024 | 3.912 |
| April 11, 2024 | 4.090 |
| April 10, 2024 | 4.019 |
| April 09, 2024 | 4.250 |
| April 08, 2024 | 3.787 |
| April 05, 2024 | 3.930 |
| April 04, 2024 | 3.876 |
| April 03, 2024 | 3.779 |
| April 02, 2024 | 3.734 |
| April 01, 2024 | 3.894 |
| Date | Value |
|---|---|
| March 28, 2024 | 4.072 |
| March 27, 2024 | 4.232 |
| March 26, 2024 | 4.268 |
| March 25, 2024 | 4.250 |
| March 22, 2024 | 4.232 |
| March 21, 2024 | 4.268 |
| March 20, 2024 | 4.392 |
| March 19, 2024 | 4.463 |
| March 18, 2024 | 4.392 |
| March 15, 2024 | 4.552 |
| March 14, 2024 | 4.125 |
| March 13, 2024 | 4.143 |
| March 12, 2024 | 3.645 |
| March 11, 2024 | 3.592 |
| March 08, 2024 | 3.716 |
| March 07, 2024 | 3.485 |
| March 06, 2024 | 3.361 |
| March 05, 2024 | 3.378 |
| March 04, 2024 | 3.450 |
| March 01, 2024 | 3.521 |
| February 29, 2024 | 3.583 |
| February 28, 2024 | 3.556 |
| February 27, 2024 | 3.725 |
| February 26, 2024 | 3.734 |
| February 23, 2024 | 3.627 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3552
Minimum
May 11 2022
8.608
Maximum
Jun 18 2021
3.135
Average
3.090
Median
Jan 19 2023
Price to Book Value Benchmarks
| uniQure NV | 1.080 |
| Merus NV | 7.916 |
| argenx SE | 5.630 |
| Pharming Group | 3.078 |
| Pharvaris NV | 2.865 |
Price to Book Value Related Metrics
| PS Ratio | 23.11 |
| Price to Free Cash Flow | 7.454 |
| Price | 2.01 |
| Earnings Yield | -18.85% |
| Market Cap | 163.52M |